Symbol Name ID |
Bbs2
Bardet-Biedl syndrome 2 MGI:2135267 |
Darker colors indicate more annotations |
Human Phenotypes | Decreased HDL cholesterol concentration |
Hypertriglyceridemia |
Elevated circulating hepatic transaminase concentration |
Decreased resting energy expenditure |
Impaired fasting glucose |
Diabetes mellitus |
Type II diabetes mellitus |
Insulin resistance |
Hepatic steatosis |
Disease(s) Associated with BBS2 | |||||||||
Bardet-Biedl syndrome | |||||||||
Bardet-Biedl syndrome 2 | |||||||||
obesity |
Mouse Phenotypes | decreased salivation |
increased circulating leptin level |
increased circulating triglyceride level |
increased circulating alanine transaminase level |
increased ceramide level |
|
Availability | Mouse Genotype | |||||
Bbs2tm1.1Huss/Bbs2tm1.1Huss | ||||||
Bbs2tm1Vcs/Bbs2tm1Vcs |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|